CHAIR
:
SPEAKER
(S):
Reni Benjamin, PhD, Senior Biotechnology Analyst, Rodman & Renshaw, LLC
Tom Amick, Chairman, Aldagen
Bruce Cohen, President and CEO, Cellerant Therapeutics, Inc.
Description
Scientists are making great strides using adult stem cells to treat a variety of diseases. Hear from industry leaders and analysts about the clinical and business opportunities and challenges in regenerative medicine.
Objectives:
Outline the most recent clinical developments in regenerative medicine and use of adult stem cells.
Improve understand about the regulatory and reimbursement challenges confronting companies using adult stem cells.
Suggest strategies for companies to maximize reimbursement.